MENU

COSCIENS Biopharma (CSCI) Ownership - Who owns COSCIENS Biopharma?

Industry: @Biotechnology

Profile

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
12.78M
P/E Ratio
N/A
Total Cash
27.8M
Projected Growth
N/A
Total Debt
1.69M
Revenue
7.68M
Risk (Beta)
0.74
Dividend Yield
N/A
Total Cash/Share
8.92
Total Debt/Equity
N/A
Revenue/Share
3.96 USD as % of share price

Fundamentals

CSCI
Capitalization
12.8M
P/E Ratio
N/A
Risk (Beta)
0.74
Dividend Yield
N/A
Total Cash
27.8M
Total Cash/Share
8.92
Total Debt
1.69M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.96%
Revenue
7.68M
ROE
N/A
Book Value
26.2M
P/B Ratio
0.49
Cash Flow
N/A
Earnings
-2.69
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
22M
Current Ratio
3.36
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-5.13M
Float
N/A
Float - Current
N/A
Gross Income Margin
35.04
Revenue To Assets
-13.75
Shares Held By Institutions
8.67K
Shares Outstanding - Current
3.12M
Total Liabilities
23.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
120.430
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A